#PRESS The first GLP-1 pill for the treatment of obesity is now broadly available across America.
Learn more in the press release here: https://t.co/a6oExpaFya
Obesity is a major contributor but still too often overlooked in cardiovascular care. Let’s bridge the gap between obesity and heart health. #AHA2025
👇 Join the conversation and vote below
Most effective step to reduce CVD risk for people with obesity?
For your commitment to our university.
For your dedication in the classroom.
For your service to our community.
For your success on the field.
For your hours of work that nobody sees.
We are grateful. We are proud.
Happy #NationalStudentAthleteDay! 🐻⬇️